1301P Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116)

Autor:	D.P. Modest, V. Heinemann, P. Schütt, S. Angermeier, M. Haberkorn, O. Waidmann, U. Graeven, K. Wille, V. Kunzmann, L. Henze, C. Constantin, M. De Wit, C. Denzlinger, A. Kurreck, A.H.S. Alig, A. Stahler, U. Pelzer, S. Stintzing, H. Oettle
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S1139
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fbc28e430a53e4ca1adeeecb5441e3fc https://doi.org/10.1016/j.annonc.2022.07.1433 Zobrazit plný text záznamu